๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adjuvant therapy for resected non-small-cell lung cancer: Recent advances, emerging agents, and lingering questions

โœ Scribed by Tara L. Lin; Julie R. Brahmer


Publisher
Current Science Inc.
Year
2004
Tongue
English
Weight
312 KB
Volume
6
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Recent advances in etoposide therapy for
โœ Philip Bonomi ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of